Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
07/2011
07/20/2011EP2344157A1 Novel inhibitors
07/20/2011EP1697312B1 Hydroxamic acid esters and pharmaceutical use thereof
07/20/2011CN1882578B 2,4 di (hetero) -arylamino-pyrimidine derivatives as zap-70 and/or syk inhibitors
07/20/2011CN102131802A New heterocyclic carboxamides for use as thrombin inhibitors
07/20/2011CN102131801A 1, 2 disubstituted heterocyclic compounds
07/20/2011CN102131800A 5- and 6-membered heterocyclic compounds
07/20/2011CN102131794A 6-substituted phenoxychroman carboxylic acid derivatives
07/20/2011CN102131785A 6-substituted isoquinolines and isoquinolinones
07/20/2011CN102131783A Quinoline derivatives as axl kinase inhibitors
07/20/2011CN102131782A Pyridine derivatives as VEGF-2 receptor and protein tyrosine kinase inhibitors
07/20/2011CN102131776A Substituted 7-sulfanylmethyl, 7-sulfinylmethyl and 7-sulfonylmethyl indoles and use thereof
07/20/2011CN102131774A Novel pyrrole derivative having, as substituents, ureide group, aminocarbonyl group and bicyclic group which may have substituent
07/20/2011CN102127060A Preparation method of atorvastatin calcium intermediate
07/20/2011CN102127058A Pyrimidine derivatives for the treatment of abnormal cell growth
07/20/2011CN102127041A Sialic acid analog and application thereof to preparation of anti-influenza-virus medicaments
07/20/2011CN102127023A 7-membered ring compound, process for producing the same, and use thereof
07/20/2011CN102127019A Geldanamycin derivative, preparation thereof and medicament application thereof
07/20/2011CN102127002A Method for preparing 3,3-diaryl substituted and 3-alkyl-3-aryl substituted oxoindole derivative
07/20/2011CN101575331B Preparation method of 5'-((5-MethoxyMethoxy-2- phenylindole-1-yl)methylene)-2'-oxo-3'- methylenetetrahydrofuran
07/20/2011CN101239971B Biphenyl derivatives
07/20/2011CN101239970B Biphenyl derivatives
07/20/2011CN101239969B Biphenyl derivatives
07/20/2011CN101239968B Biphenyl derivatives
07/19/2011US7982043 Protein tyrosine kinase enzyme inhibitors
07/19/2011US7982042 Thiozanthene derivatives as delta-opioid modulators
07/19/2011US7982041 Camptothecin analogs and methods of preparation thereof
07/19/2011US7982037 (5-Methyl-2H-pyrazol-3-yl)-(2-phenylsulfanyl-quinazolin-4-yl)-amine; Anticancer agents; antidiabetic agents; Alzheimer's disease; inhibitors of Aurora-2 and GSK-3
07/19/2011US7981907 Thio-substituted biarylmethanesulfinyl derivatives
07/19/2011US7981894 Polymorphic forms of 1-′4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
07/19/2011US7981889 e.g. 4-[5-(Piperidine-1-carbonyl)-furan-2-ylmethyl]-2H-phthalazin-1-one; enzyme poly(ADP-ribose)polymerase (synthase)-1 or poly ADP-ribosyltransferase (PARP-1) inhibitor; anticarcinogenic agent with BRCA2 deficient phenotype; septic shock; ischemic injury; hemorrhagic shock; multiple sclerosis
07/19/2011US7981882 e.g. 7-Chloro-3-(2,2,2-trifluoroacetyl)-6-trifluoromethanesulfonyloxy-2,3,4,5-tetrahydro-1H-benzo[d]azepine; antidepressant, anxiolytic agent; obesity, obsessive/compulsive disorder
07/19/2011CA2637774C Nucleosides with anti-hepatitis b virus activity
07/19/2011CA2476186C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
07/19/2011CA2448561C Aminoquinoline derivatives and their use as adenosine a3 ligands
07/19/2011CA2344169C Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
07/19/2011CA2237590C Cyclic and heterocyclic n-substituted .alpha.-iminohydroxamic and -carboxylic acids
07/14/2011WO2011084922A1 Pro-drugs of (e) -7- (3- (2-amino-1-fluoroethylidene) piperidin-1-yl) -1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
07/14/2011WO2011083804A1 Indole derivative
07/14/2011WO2011083495A2 Process for the preparation of dihydroxy protected derivatives and novel intermediate compounds
07/14/2011WO2011082519A1 Geldanamycin derivatives, preparation methods and uses thereof
07/14/2011WO2008126106A3 Novel and improved processes for the preparation of intermediates of darifenacin, darifenacin and its pharmaceutically acceptable salts
07/14/2011US20110172442 Amino acid derivative
07/14/2011US20110172440 Rosin derived epoxides and curing agents
07/14/2011US20110172434 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
07/14/2011US20110172420 Sulfonamide derivatives of polycyclic dyes used for analytical applications
07/14/2011US20110172415 Nitrogen-containing heterocycle derivatives substituted with cyclic group
07/14/2011US20110172297 Oxopiperdinyl And Pyranyl Sulfonamides and Pharmaceutical Compositions Thereof
07/14/2011US20110172270 2-'4(phenylamino)-piperidin-1-yl!-n-phenyl-acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatment of obesity
07/14/2011US20110172261 DIBENZO[f,h]ISOQUINOLINE DERIVATIVES
07/14/2011US20110172244 Compounds and compositions as modulators of gpr119 activity
07/14/2011US20110172225 Antifungal agents
07/14/2011US20110172212 Amine-based compound and use thereof
07/14/2011US20110172193 Pro-drugs of (e)-7-(3-(2-amino-1-fluoroethylidene)piperidin-1-yl)-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
07/14/2011US20110171736 Fluorescent isotope tags and their method of use
07/14/2011US20110171171 Bridged secondary amines and use thereof as iap bir domain binding compounds
07/14/2011CA2782347A1 Quinoline amide m1 receptor positive allosteric modulators
07/13/2011EP2343292A1 Novel prostaglandin i<sb>2</sb>derivative
07/13/2011EP2343282A1 Diaminopyrimidines as P2X3 and P2X2/3 antagonists
07/13/2011EP2343069A1 Heterocyclic aspartyl protease inhibitors
07/13/2011EP2342200A2 Compounds which selectively modulate the cb2 receptor
07/13/2011EP2342199A2 Compounds which selectively modulate the cb2 receptor
07/13/2011EP2342197A1 Radiolabelled inhibitors of the glycine 1 transporter
07/13/2011EP2342191A1 Aromatic nitrogen-containing 6-membered ring compounds and their use
07/13/2011EP2342188A1 Chromenone analogs as sirtuin modulators
07/13/2011EP1720857B1 Dihydropyridinone derivatives
07/13/2011EP1697327B1 Insecticidal spiroindane derivatives
07/13/2011EP1539717B1 Microbiocidal (e.g fungicidal) 1,2,3-triazole derivatives
07/13/2011CN1871233B Novel chelating agents and chelates and their use
07/13/2011CN102124000A Pyridine compounds
07/13/2011CN102123991A 2 -arylaminoquinazolines for treating proliferative diseases
07/13/2011CN102123987A Cycloalkylidene and heterocycloalkylidene histone deacetylase inhibitor compounds
07/13/2011CN101484446B Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and agents containing said compounds
07/12/2011US7977477 Benzimidazole derivatives and their use as protein kinase inhibitors
07/12/2011US7977466 C-glycoside derivatives and salts thereof
07/12/2011US7977465 Peptidyl prodrugs and linkers and stabilizers useful therefor
07/12/2011US7977387 Aminobenzophenone compounds
07/12/2011US7977371 Pyrrole derivative having ureido group and aminocarbonyl group as substituents
07/12/2011US7977333 Substituted pyridines and pyridazines with angiogenesis inhibiting activity
07/12/2011US7977332 Insecticidal N-(heteroarylalkyl)alkanediamine derivatives
07/12/2011US7977322 Such as 1-Benzo[1,3]dioxol-5-yl-cyclopropanecarboxylic acid [5-(2-methoxy-pyridin-3-ylmethyl)-thiazol-2-yl]-amide 5-(2-Methoxy-pyridin-3-ylmethyl)-thiazol-2-ylamine; cystic fibrosis transmembrane conductance regulator disorders
07/12/2011CA2585053C Substituted n-acyl (hetero)aryl compounds as c-fms kinase inhibitors
07/12/2011CA2582479C Benzoimidazole derivatives useful as antiproliferative agents
07/12/2011CA2517629C Phthalazinone derivatives
07/12/2011CA2445341C Anthranilamides, process for their preparation, their use as antiarrhythmics, and pharmaceutical preparations thereof
07/12/2011CA2431617C 7-heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone
07/12/2011CA2389685C Novel heterocyclic compounds and their use as medicaments
07/07/2011WO2011082354A2 Thiol detection
07/07/2011WO2011082077A1 Hepatitis c virus inhibitors
07/07/2011WO2011080751A2 α4β2 NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS
07/07/2011WO2011080256A1 Fungicide hydroximoyl-tetrazole derivatives
07/07/2011WO2011080254A2 Fungicide hydroximoyl-heterocycles derivatives
07/07/2011US20110166360 Catalytic Process for Asymmetric Hydrogenation
07/07/2011US20110166181 Guanidine compounds as anesthetics and for treatment of nervous system disorders
07/07/2011US20110166132 Gamma Secretase Modulators
07/07/2011US20110165229 Compositions and Methods for Treatment
07/07/2011US20110165225 Modified Drugs for Use in Liposomal Nanoparticles
07/07/2011CA2785957A1 .alpha.4.beta.2 neuronal nicotinic acetylcholine receptor ligands
07/06/2011EP2340252A1 A process for preparing [1s- ]1-alpha, 2-alpha, 3-beta (1s*, 2r*) 5-beta] ]-3- [7- [2- (3, 4-dif luorophenyl) -cyclopropylamino]- 5- (propylthio) -3h-1, 2, 3-triazolo [4, 5-d]pyrimidin-3-yl]-5- (2- hydroxyethoxy) cyclopentane-1, 2-diol and to its intermediates
07/06/2011EP2340244A1 Compounds and methods of use
07/06/2011EP2340243A1 Heteroaryl substituted indole compounds useful as mmp-13 inhibitors